HCDs–DOX was prepared with low cytotoxicity, and sustained, pH-targeted release properties. In vitro release conformed to the Weibull model and Fick diffusion.

In distributed training of deep neural networks or Federated Learning (FL), people usually run Stochastic Gradient Descent (SGD) or its variants on each machine and communicate with other machines periodically. However, SGD might converge slowly in training some deep neural networks (e.g., RNN, LSTM) because of the exploding gradient issue. Gradient clipping is usually employed to address this issue in the single machine setting, but exploring this technique in the FL setting is still in its infancy: it remains mysterious whether the gradient clipping scheme can take advantage of multiple machines to enjoy parallel speedup. The main technical difficulty lies in dealing with nonconvex loss function, non-Lipschitz continuous gradient, and skipping communication rounds simultaneously. In this paper, we explore a relaxed-smoothness assumption of the loss landscape which LSTM was shown to satisfy in previous works and design a communication-efficient gradient clipping algorithm. This algorithm can be run on multiple machines, where each machine employs a gradient clipping scheme and communicate with other machines after multiple steps of gradient-based updates. Our algorithm is proved to have O 1 N 4 iteration complexity for finding an -stationary point, where N is the number of machines. This indicates that our algorithm enjoys linear speedup. We prove this result by introducing novel analysis techniques of estimating truncated random variables, which we believe are of independent interest. Our experiments on several benchmark datasets and various scenarios demonstrate that our algorithm indeed exhibits fast convergence speed in practice and thus validates our theory.

Dilated cardiomyopathy (DCM) is the major cause of heart failure and has a poor prognosis. The accumulating evidence points to an essential role of the inflammatory component in the process of DCM. Inhibitors of sodium-glucose cotransporter 2 (SGLT2) are widely used to treat heart failure patients due to their cardiac benefits. However, their role in DCM remains unclear. We used the doxorubicin (Dox)-induced DCM model for our study. The SGLT2 inhibitor dapagliflozin (Dapa) improved cardiac function in mice treated with doxorubicin and attenuated the activation of the nucleotide-binding oligomerization domain-like receptor family protein 3 (NLRP3) inflammasome pathway and the expression of inflammatory factors. In addition, dapagliflozin suppresses NLRP3 activation by decreasing p38-dependent toll-like receptor 4 (TLR4) expression. In our study, dagliflozin improves cardiac function in DCM by inhibiting the activity of the NLRP3 inflammasome. Graphical Abstract

No abstract